Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Photorevive Inc. has 2 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 1 distinct examiner and 1 distinct art unit, so the reported activity is concentrated in a single examination channel.
D ABREU, MICHAEL JOSEPH is the busiest examiner, with 2 pending matters. Counsel can coordinate the responses closely, using consistent device terminology and addressing any common examination issues together where appropriate.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| D ABREU, MICHAEL JOSEPH | 2 | 67.7% | +21.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18753878 | AI DRIVEN PLATFORM TO USE INFRARED LIGHT TO TREAT INFLAMMATORY CYTOKINE STORMS | D ABREU, MICHAEL JOSEPH | 62d |
| 19001481 | COMBINED THERAPEUTIC MODALITIES FOR REDUCING INFLAMMATION | D ABREU, MICHAEL JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19001481 | COMBINED THERAPEUTIC MODALITIES FOR REDUCING INFLAMMATION | D ABREU, MICHAEL JOSEPH | 3796 | §103 | Non-Final OA | — | Pending | Dec 25, 2024 |
| 18753878 | AI DRIVEN PLATFORM TO USE INFRARED LIGHT TO TREAT INFLAMMATORY CYTOKINE STORMS | D ABREU, MICHAEL JOSEPH | 3796 | §103 | Final Rejection | 62d | Pending | Jun 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPhotorevive Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael Joseph D Abreu has the most, with 2 of Photorevive Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
